Kintara Therapeutics, Inc. (KTRA) Social Stream



Kintara Therapeutics, Inc. (KTRA): $0.22

0.04 (+20.67%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add KTRA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#231 of 385

in industry

KINTARA THERAPEUTICS INC (KTRA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering KTRA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 3 $6 $3 $4.562 $0.141 3135.46%
2021-12-02 3 $6 $3 $4.75 $0.141 3268.79%
2022-02-14 2 $250 $250 $250 $0.141 177204.96%
2022-03-18 3 $5 $3 $4 $0.141 2736.88%
2022-04-08 2 $5 $1.5 $3.25 $0.141 2204.96%
2022-04-12 2 $5 $1.5 $3.166 $0.141 2145.39%
2023-09-08 2 $14 $14 $14 $0.141 9829.08%
NA 2 $NA $NA $NA $0.141 NA%

The Trend in the Analyst Price Target


Over the past 31 months, KTRA's average price target has gone up $8.5.

Over the past 56 days, KTRA's average upside potential has been 209.37%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-07-14 2 14 14 14 4.64 201.72%
2023-07-21 2 14 14 14 4.47 213.2%
2023-09-08 2 14 14 14 4.47 213.2%

KTRA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


KTRA's average broker recommendation rating worsened by 1.33 over the prior 19 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • KINTARA THERAPEUTICS INC's number of analysts covering the stock is higher than 56.49% of all US stocks.
  • KINTARA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1092.57% of all US stocks.
  • In the context of Healthcare stocks, KINTARA THERAPEUTICS INC's average analyst price target is greater than 157.65% of them.
  • To contextualize these metrics, consider that out of stocks in the micro market cap category, KINTARA THERAPEUTICS INC's variance in analysts' estimates is lower than -546.89% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KINTARA THERAPEUTICS INC are ATXI, LPTX, and PULM.

Make investment decisions regarding KTRA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!